Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 23, 2000

View Archived Issues

Immune Response synthesizes new factor VIII gene

Cantab makes steady progress during 1999

Reticulose cleared for clinical trials in Argentina

FDA advisory committee meeting canceled

OSI Pharmaceuticals makes forward strides during Q1 2000

NCI begins phase II trial of O6-benzylguanine/carmustine as glioma therapy

Biomira updates product pipeline

Gilead reviews progress in 1999

Oxigene to develop CA4P for eye, skin and joint disorders

Life-saving treatment for pulmonary hypertension in newborn babies featured in NEJM

New phenethylsulfones synthesized at Celgene useful for inflammation, etc.

Lilly's new 5-ht1f receptor antagonists covered by two European patents

Cell Pathways presents apoptosis-promoting compounds

Gene therapy improves age-related cardiac disorder in rats

New compounds with ampakine-like activity in development at Lilly

Novirio claims large group of HIV RT inhibitors

Cantharidin analogues as protein phosphatase inhibitors: use in cancer therapy

Antiparasitic artemisinin derivatives designed at Hong Kong university

New antiepileptic Diastat available in Canada for ARS

Early clinical trial in Japan demonstrates safety, favorable pharmacokinetics of CGS-19755

CPMP issues positive opinion regarding PEG-Intron MAA

Antifungal activity of brasilinolide B described by Japanese research team

Switch Biotech files patent applications for wound-healing genes

Approvable letter issued by FDA for Texas Biotechnology's Novastan

Paladin licenses Uniprost to United Therapeutics in Canada

Trichobitacin: anti-HIV RIP purified from Chinese medicinal herb

Monsanto and P&U to hold special shareholder meetings to vote on proposed merger

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...